Apollo Therapeutics
Cambridge, GB · 66 employees on LinkedIn · 4 known investors
Apollo Therapeutics is a portfolio biopharmaceutical company that translates academic biology and medical research into new medicines, operating over 20 therapeutic programs including six in clinical development. It runs an R&D platform partnered with leading universities and research institutes, and also in-licenses or acquires clinical-stage programs, with operations in Cambridge and Oxford, UK, and Boston and Chicago, USA.</parameter> <parameter name="founders">[]
Investors · 4
Funding
SEC filings, press & company announcements- Undisclosed amountSeries CSep 2023
Patient Square Capital (lead)
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Apollo Therapeutics do?
- Apollo Therapeutics is a portfolio biopharmaceutical company that translates academic biology and medical research into new medicines, operating over 20 therapeutic programs including six in clinical development. It runs an R&D platform partnered with leading universities and research institutes, and also in-licenses or acquires clinical-stage programs, with operations in Cambridge and Oxford, UK, and Boston and Chicago, USA.</parameter> <parameter name="founders">[]
- Who are Apollo Therapeutics's investors?
- Apollo Therapeutics's investors include Patient Square Capital, Rock Springs Capital, AlbionVC, UCL Technology Fund.
- Where is Apollo Therapeutics headquartered?
- Apollo Therapeutics is headquartered in Cambridge, GB.